The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
9 marketed package NDCs · 2 active manufacturers
Most dispensed: AMYLASE 60000 [USP'U]; LIPASE 12000 [USP'U]; PROTEASE 38000 [USP'U] · Capsule, Delayed Release Pellets · #100 capsule, delayed release pellets/bottle · LIPASE 24000 [USP'U]; PROTEASE 76000 [USP'U]; AMYLASE 120000 [USP'U] · Capsule, Delayed Release Pellets · #100 capsule, delayed release pellets/bottle · LIPASE 36000 [USP'U]; AMYLASE 180000 [USP'U]; PROTEASE 114000 [USP'U] · Capsule, Delayed Release Pellets · #100 capsule, delayed release pellets/bottle · AMYLASE 30000 [USP'U]; LIPASE 6000 [USP'U]; PROTEASE 19000 [USP'U] · Capsule, Delayed Release Pellets · #1 bottle/carton / 100 capsule, delayed release pellets in 1 bottle
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Every detected change for pancrelipase, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.